Related Experiment Video
Updated: Feb 28, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Pharmaceutical Utilization Review: A Five-Year Time Trend Analysis of the Pharmaceutical Market in Iran
Mohammadamir Nemati1, Behzad Fatemi1,2, Fatemeh Soleymani1,2
1Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Background And Objectives:
The primary objective of this study was to compare the total and insurance-covered utilization of pharmaceuticals in Iran from March 2018 to March 2023. The findings of this study can offer valuable insights to healthcare professionals, researchers, and policymakers to make informed decisions.
Methods:
A retrospective cross-sectional study in Iran examined drug utilization patterns (specific databases, e.g., Iranian Health Insurance Organization and Social Security Organization) using Joinpoint regression. The study calculated the Defined Daily Doses per 1000 inhabitants per day (DID) for each medicine based on the anatomical therapeutic chemical/defined daily dose (ATC/DDD) system. All medicines with valid ATC/DDD assignments available during 2018 - 2023 were included to ensure comprehensive national coverage rather than a selected sample. Joinpoint regression was employed for trend analysis, focusing on annual and monthly percent changes in pharmaceutical utilization. Statistical analysis was conducted using MS Excel and Joinpoint software, with significance set at P-value < 0.05.
Results:
The study assessed 1185 ATC codes, out of which 751 were found eligible for analysis. Among these, 728 were covered by two major Iranian insurance organizations. The study found that the share of insurance utilization of these pharmaceuticals ranged from 27 to 48 percent. The trend utilization showed significant increases in overall utilization in classes C, J, L, N, and P. The utilization trends under insurance coverage revealed that classes L, R, and S showed a significant increase. After the implementation of the Daruyar Plan and the removal of the preferred currency exchange rate for all classes, there has been an increase in utilization under insurance coverage.
Conclusions:
This study reveals notable patterns and discrepancies in utilization levels within different drug classes, as well as the impact of insurance coverage and the Daruyar Plan on medication utilization.
More Related Videos
09:24Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
06:08Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Pharmaceutical Equivalents
Drug Dissolution: Requirements and Profile Comparison
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Therapeutic Drug Monitoring: Affecting Factors